Literature DB >> 32185504

Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery.

Eva Havers-Borgersen1, Jawad H Butt2, Lauge Østergaard2, Henning Bundgaard2, Morten Smerup3, Niels Eske Bruun4,5,6, Gunnar H Gislason7, Christian Torp-Pedersen8, Lars Køber2, Emil L Fosbøl2.   

Abstract

OBJECTIVE: Infective endocarditis (IE) may require heart valve surgery. It is well known that heart valve surgery itself and previous IE predispose to IE. However, data are sparse on whether the risk of IE is different among patients undergoing valve surgery due to IE and other causes (i.e. recurrent vs. first-time IE).
METHODS: Using Danish nationwide registries, patients undergoing left-sided heart valve surgery in the course of an IE hospitalization (1996-2017) were identified and matched with controls undergoing left-sided heart valve surgery due to another cause than IE in a 1:1 ratio. Patients were stratified according to type of surgical valve intervention and affected valve. The comparative risk of recurrent vs. first-time IE was assessed by cumulative incidence curves and multivariable Cox regression analyses.
RESULTS: The study population comprised 971 patients with a first-time admission for IE requiring heart valve surgery matched with 971 controls undergoing heart valve surgery due to other causes than IE. The risk of recurrent IE was significantly higher than the risk of first-time IE following heart valve surgery (5.5% and 3.0% by 10 years, hazard ratio (HR) 1.66, 95% confidence interval (CI) 1.02-2.70). The risk of IE recurrence was not significantly different comparing valve replacement and valve repair (5.5% and 5.3%, respectively, HR 1.60, 95% CI 0.71-3.60). Yet, the risk of IE recurrence was significantly higher among patients with biological versus mechanical prostheses (6.3% and 4.6%, respectively, HR 2.00, 95% CI 1.02-3.70).
CONCLUSIONS: Following heart valve surgery, the risk of recurrent IE was significantly higher than the risk of first-time IE.

Entities:  

Keywords:  Epidemiology; Heart valve disease; Heart valve surgery; Infective endocarditis

Year:  2020        PMID: 32185504     DOI: 10.1007/s00392-020-01628-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  3 in total

1.  Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial.

Authors:  Johan S Bundgaard; Kasper Iversen; Mia Pries-Heje; Nikolaj Ihlemann; Sabine U Gill; Trine Madsen; Hanne Elming; Jonas A Povlsen; Niels E Bruun; Dan E Høfsten; Kurt Fuursted; Jens J Christensen; Martin Schultz; Flemming Rosenvinge; Jannik Helweg-Larsen; Lars Køber; Christian Torp-Pedersen; Emil L Fosbøl; Niels Tønder; Claus Moser; Henning Bundgaard; Ulrik M Mogensen
Journal:  Qual Life Res       Date:  2022-03-29       Impact factor: 3.440

2.  Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: A nationwide study.

Authors:  Eva Havers-Borgersen; Emil L Fosbøl; Jawad H Butt; Jeppe K Petersen; Andreas Dalsgaard; Frederik Kyhl; Morten Schou; Matthew Phelps; Kristian Kragholm; Gunnar H Gislason; Christian Torp-Pedersen; Lars Køber; Lauge Østergaard
Journal:  Int J Cardiol Heart Vasc       Date:  2020-11-06

3.  The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology.

Authors:  Christina Armstrong; Tim Christian Kuhn; Florian Leuschner; Alexandra Heininger; Matthias Dufner; Philipp Ehlermann; Stefan Zimmermann; Christoph Lichtenstern; Jasmin Soethoff; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2020-06-02       Impact factor: 5.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.